Wall Street Analysts See a 360.53% Upside in Abivax SA Sponsored ADR (ABVX): Can the Stock Really Move This High?

Group 1 - Abivax SA Sponsored ADR (ABVX) shares have increased by 29.5% over the past four weeks, closing at $7.60, with a mean price target of$35 indicating a potential upside of 360.5% [1] - The average of seven short-term price targets ranges from a low of $12 to a high of$50, with a standard deviation of $14.12, suggesting a potential increase of 57.9% to 557.9% from the current price [2] - Analysts show strong agreement in revising earnings estimates higher, with the Zacks Consensus Estimate increasing by 10.2% over the last 30 days, indicating positive earnings prospects for ABVX [10][11] Group 2 - The Zacks Rank for ABVX is 2 (Buy), placing it in the top 20% of over 4,000 ranked stocks based on earnings estimates, which supports the stock's potential upside [11] - While price targets are often viewed skeptically, the direction implied by these targets can serve as a useful guide for potential price movements [12]